Bios

BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies — the next frontier in precision medicine. The company has developed proprietary neural interfaces and an AI platform that can read and write the body's neural data in real-time, both in acute and chronic settings. BIOS discovers neural biomarkers that precisely link nerve activity to specific conditions, enabling targeted pharmaceutical development and software-delivered therapies. Its research targets conditions including hypertension, diabetes, rheumatoid arthritis, Parkinson's, and Alzheimer's disease. Co-founded by Cambridge University researchers Emil Hewage (computational neuroscientist) and Oliver Armitage (biomechanical engineer), the BIOS team brings over 300 peer-reviewed publications, 10+ first-of-kind medical devices, and 6,000+ clinical procedures of combined experience.